Articles and Insights About Wearables for Clinical Trials

Patient-Centricity

Novel Digital Sleep Assessment Tools in Major Depressive Disorder

 VivoSense Team

VivoSense published a Karger review article, The Case for the Patient-Centric Development of Novel Digital Sleep Assessment Tools in Major Depressive Disorder.

Read More

Examples of Patient-Centric Digital Measures for Rett Syndrome

 Robert Wright, PhD

On June 7th, 2023, Robert Wright, PhD, Senior Research Scientist at VivoSense, and Jana Von Hehn, PhD, CSO at Rett Syndrome Research Trust, presented at the Digital Health Innovation Summit, a forum to learn from the best about top trends in the industry. Their presentation, Developing Patient-Centric Real-World Digital Clinical Measures for Rett Syndrome, summarized years of collaborative work implementing digital health technologies in complex research programs.

Read More

Implementing Patient-Centric Solutions in Digital Evidence Generation

 Ieuan Clay, PhD

We all know it's important to choose “measures that matter” when selecting and developing digital measures for evidence generation in clinical trials, but how do we put these good intentions into action? How do we lay solid, patient-centric foundations, whether that means designing a protocol, building an integrated evidence plan, or qualifying a novel evidence tool?

Read More

The Importance of Patients as Partners in Alzheimer's Disease Research

 Jen Blankenship, PhD

Jen Blankenship, PhD, Senior Research Scientist, moderated a lively discussion with Shelby Bachman, PhD, Research Scientist, and an expert panel about the promise of Digital health technologies (DHTs) like smartphones and wearable sensors to advancing drug development and discovery in neurodegenerative diseases, particularly Alzheimer’s disease.

Read More

Reverse Engineering Digital Measures: A Patient-Centric Approach

 Ieuan Clay, PhD

In September 2022, a broad range of stakeholders representing regulators, Pharma and Biotech firms, technology service providers, innovators, and patients gathered in Zürich. This meeting, the second in a series hosted by the Swiss Federal Institute of Technology and the Foundation for the National Institutes of Health Biomarkers Consortium, sought to explore the role patient centricity must play in the development and validation of digital tools for gathering evidence. Director of Science Ieuan Clay, a member of the Biomarkers Consortium, represented VivoSense in the discussion examining four case studies of interest:

Read More

VivoSense Joins the FNIH Biomarkers Consortium

 Dudley Tabakin

VivoSense announces that we have joined the Foundation for the National Institutes of Health’s (FNIH) Biomarkers Consortium! This new partnership strengthens our joint mission to facilitate the development of novel digital biomarkers using new and existing technologies, including evidence for their qualification in diagnostic medicine, therapeutic development, and clinical practice improvement.

Read More
 Newer All Articles Older 

Stay Connected

Popular